Changes in the degree of ventricular hypertrophy following administration of Losartan potassium compared to L-NAME (L – Arginine Methyl Ester)
Changes in the degree of ventricular hypertrophy following administration of Losartan potassium compared to L-NAME (L – Arginine Methyl Ester)
dc.contributor.author | Muhanad S A | |
dc.contributor.author | Abdelwahab H M | |
dc.contributor.author | Osman K A | |
dc.date.accessioned | 2022-10-23T14:31:53Z | |
dc.date.available | 2022-10-23T14:31:53Z | |
dc.date.issued | 2022-07 | |
dc.description.abstract | Background: The main goal of the study is to investigate the effect of Losartan on the degree of heart hypertrophy compared to L-NAME, also is this changes associated with redistribution of the left ventricular MHCs ratio? Methods: forty six white adult Swiss mice CD1 (weight range between 18g and 33g, and their ages range between 8-10 weeks) were used in this study. Animals were distributed randomly into four groups, each consist of eleven mice as follows: Control group left without treatment during the whole period of the study, group A ( given 600mg/L of L-NAME) , group B (given Losartan potassium 1g/L and L-NAME 600mg/L), and group S ( given 1g/L of Losartan potassium). All treatment were mixed with the drinking water , and given for 35 days. Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis (SDS-PAGE) was used for the separation of the ventricular myocin heavy chains. Results: Administration of Losartan either alone or in combination with L-NAME cause’s significant decreases in the HW/BW ratio with P values 0.000 &0.000 respectively, and this reduction in the degree of the heart hypertrophy shows a shift in α: β ratio towards β LVMHCs compared to control (P values 0.000 &0.001 respectively). While L-NAME treatment in the group A cause’s marginal insignificant increase in HW/BW ratio, P values 0.054, with shifting of α: β MHCs ratio towards β LVMHCs compared to control P values 0.019 . Conclusion: L-NAME treatment changed the LVMHCs from alpha to beta, and this changing occurs before left ventricular hypertrophy. Also treatment with Losartan either alone or in combination with L-NAME produced a shift in the α: β ratio towards β LVMHCs with a decrease in the HW/BW ratio | |
dc.description.sponsorship | Napata College | |
dc.identifier.issn | 2948-300X | |
dc.identifier.issn | 2948-3018 | |
dc.identifier.uri | http://dspace.napata.edu.sd/handle/123456789/20 | |
dc.language.iso | en | |
dc.publisher | Napata College | |
dc.title | Changes in the degree of ventricular hypertrophy following administration of Losartan potassium compared to L-NAME (L – Arginine Methyl Ester) | |
dc.type | Article |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Changes in the degree of ventricular hypertrophy following administration of Losartan potassium compared to L-NAME (L – Arginine Methyl Ester).pdf
- Size:
- 711.44 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed to upon submission
- Description: